These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 21944027)

  • 1. Chairperson's introduction: Despite significant advances in the diagnosis and treatment of breast cancer, approximately one third of patients still develop, and subsequently die from metastatic breast disease.
    Johnston SR
    Eur J Cancer; 2011 Sep; 47 Suppl 3():S4-5. PubMed ID: 21944027
    [No Abstract]   [Full Text] [Related]  

  • 2. Introduction: Current and future approaches to chemotherapy in patients with resistant breast cancer.
    Burstein HJ
    Semin Oncol; 2011 Jun; 38 Suppl 2():S1-2. PubMed ID: 21600379
    [No Abstract]   [Full Text] [Related]  

  • 3. Chairperson's introduction: Survival of patients with metastatic colorectal cancer has dramatically improved over the last decade.
    van de Velde CJ
    Eur J Cancer; 2011 Sep; 47 Suppl 3():S50-1. PubMed ID: 21944028
    [No Abstract]   [Full Text] [Related]  

  • 4. Initially metastatic breast carcinoma has a distinct disease pattern but an equivalent outcome compared with recurrent metastatic breast carcinoma.
    Jimeno A; Amador ML; González-Cortijo L; Tornamira MV; Ropero S; Valentín V; Hornedo J; Cortés-Funes H; Colomer R
    Cancer; 2004 May; 100(9):1833-42. PubMed ID: 15112263
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Survival from breast cancer in England and Wales up to 2001.
    Leary A; Smith IE
    Br J Cancer; 2008 Sep; 99 Suppl 1(Suppl 1):S56-8. PubMed ID: 18813261
    [No Abstract]   [Full Text] [Related]  

  • 6. Treatment of patients with inflammatory breast cancer.
    Swain SM; Lippman ME
    Important Adv Oncol; 1989; ():129-50. PubMed ID: 2651284
    [No Abstract]   [Full Text] [Related]  

  • 7. [Third revision of the National Consensus on Diagnosis and Treatment of Breast Cancer (second of three parts)].
    Ginecol Obstet Mex; 2010 Feb; 78(2):138-50. PubMed ID: 20939218
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The natural history of breast carcinoma in patients with > or = 10 metastatic axillary lymph nodes before and after the advent of adjuvant therapy: a multiinstitutional retrospective study.
    Montero AJ; Rouzier R; Lluch A; Theriault RL; Buzdar AU; Delaloge S; Bermejo B; Le M; Kau SW; Dunant A; Arriagada R; Spielmann M; Garcia-Conde J; Sahin AA; Singletary SE; Hortobagyi GN; Valero V
    Cancer; 2005 Jul; 104(2):229-35. PubMed ID: 15937910
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Inflammatory carcinoma of the breast. Our experience].
    Punzo C; Leo G; Palmiotti G; Cito D; Berardi T
    Minerva Med; 1989 Aug; 80(8):907-11. PubMed ID: 2797492
    [No Abstract]   [Full Text] [Related]  

  • 10. Ten years of experience with weekly chemotherapy in metastatic breast cancer patients: multivariate analysis of prognostic factors.
    Nisticò C; Cuppone F; Bria E; Fornier M; Giannarelli D; Mottolese M; Novelli F; Natoli G; Cognetti F; Terzoli E
    Anticancer Drugs; 2006 Nov; 17(10):1193-200. PubMed ID: 17075319
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Breast carcinoma in men: a review of 21 cases].
    Benito Ruiz J; del Pino Porres J; Carbonell Tatay F
    Rev Clin Esp; 1990 Nov; 187(7):325-8. PubMed ID: 2091111
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inflammatory breast carcinoma: outcomes with trimodality therapy for nonmetastatic disease.
    Liauw SL; Benda RK; Morris CG; Mendenhall NP
    Cancer; 2004 Mar; 100(5):920-8. PubMed ID: 14983486
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of locoregional therapy in inflammatory breast cancer.
    Woodward WA; Buchholz TA
    Semin Oncol; 2008 Feb; 35(1):78-86. PubMed ID: 18308149
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tracking the seed and tending the soil: evolving concepts in metastatic breast cancer.
    Comen EA
    Discov Med; 2012 Aug; 14(75):97-104. PubMed ID: 22935206
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular markers of breast axillary lymph node metastasis.
    Cavalli LR
    Expert Rev Mol Diagn; 2009 Jul; 9(5):441-54. PubMed ID: 19580429
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Current management of primary breast cancer. Part I: Screening, diagnosis, staging and local treatment of stage I and II disease.
    Lopez MJ; Andriole DP
    Mo Med; 1990 Sep; 87(9):684-90. PubMed ID: 2215472
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The management of early breast carcinoma before and after the introduction of clinical practice guidelines.
    White V; Pruden M; Giles G; Collins J; Jamrozik K; Inglis G; Boyages J; Hill D
    Cancer; 2004 Aug; 101(3):476-85. PubMed ID: 15274060
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Primary inflammatory carcinoma of the female breast: staging and treatment possibilities.
    McBride CM; Hortobagyi GN
    Surgery; 1985 Oct; 98(4):792-8. PubMed ID: 4049251
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The therapy of advanced breast carcinoma in men].
    Renziehausen L; Quietzsch D
    Dtsch Med Wochenschr; 1992 Jan; 117(5):172-6. PubMed ID: 1735376
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Targeted based therapies in metastatic breast cancer: future evolution].
    Belmondo L; Montana M; Curti C; Crozet M; Rathelot P; Penot-Ragon C; Vanelle P
    Therapie; 2012; 67(6):491-503. PubMed ID: 23249575
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.